This work could also improve
the early diagnosis of lung cancer and lead to the identification of new therapeutic targets.
Not exact matches
Research Paper Serum VEGF levels in the
early diagnosis and severity assessment
of non-small cell
lung cancer Yanzhen Lai, Xueping Wang, Tao Zeng, Shan Xing, Shuqin Dai, Junye Wang, Shulin Chen, Xiaohui Li, Ying Xie, Yuanying Zhu, Wanli Liu J. Cancer 2018; 9 (9): 1538 -
cancer Yanzhen Lai, Xueping Wang, Tao Zeng, Shan Xing, Shuqin Dai, Junye Wang, Shulin Chen, Xiaohui Li, Ying Xie, Yuanying Zhu, Wanli Liu J.
Cancer 2018; 9 (9): 1538 -
Cancer 2018; 9 (9): 1538 - 1547.
Clinical Trials Research and Billing First in Human /
Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State
of the Art Spondylodiscitis: Role
of Imaging for
Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity
of Radioactive Iodine for Metastatic Thyroid
Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging
of Lung Inflammation Standardization
of Advanced PET / SPECT Data Acquisition and Analysis Thyroid
Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
Conclusions This review provides preliminary evidence that smoking cessation after
diagnosis of early stage
lung cancer improves prognostic outcomes.
We reviewed 10 observational studies, all
of which showed some evidence that people who continue to smoke after a
diagnosis of early stage
lung cancer have an associated higher risk
of recurrence, second primary tumour, or all cause mortality compared with those who stop smoking at that time.
Potential applications include in vivo microscopic assessment
of early bronchial
cancers, bronchial wall remodelling evaluation and diffuse peripheral
lung disease exploration, as well as in vivo
diagnosis of peripheral
lung nodules.